An executive accused of illegally profiting from inside knowledge of his company’s promising new cancer drug jumped to his death from an airport parking garage in New Jersey. Zizhong Fan, manager of clinical programming at Seattle Genetics, is believed to have shared insider information on clinical trials involving the company’s…
Read the original post:
Insider Trading Suspect Jumps to His Death